The increasing incidence of chronic wounds is a significant healthcare concern globally. Factors contributing to this trend include rising cases of diabetes, obesity, and vascular diseases, which are known risk factors for chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers.
Additionally, growing aging population and longer life expectancy contributes to the prevalence of chronic wounds, as older individuals are more susceptible to conditions that impair wound healing, such as decreased mobility and compromised immune function.
Addressing this growing burden of chronic wounds requires effective wound management strategies, including the use of advanced wound dressings that promote healing, prevent infection, and enhance patient comfort.
Moreover, accidents and injuries resulting from road accidents, workplace incidents, and sports injuries, further contribute to the rising number of acute wounds requiring medical attention.
All these factors collectively contribute to increased demand for effective wound dressings, thereby driving the market growth.
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
The global biomaterial wound dressing market size was USD 5.8 billion in 2023 and is expected to grow at 6.4% CAGR during 2024- 2032, propelled by increasing demand for advanced wound care solutions.
The natural segment will record 6.2% CAGR between 2024-2032, owing to the ease of availability and cost-effectiveness of natural biomaterials.
North America biomaterial wound dressing market is predicted to reach USD 4 billion by 2032, attributed to advanced healthcare infrastructure and facilities, including hospitals, specialty clinics, and ambulatory surgical centers, that facilitate wound care.
3M, B. Braun Melsungen AG, ConvaTec Group plc., DermaRite Industries LLC, Hollister Incorporated, Integra LifeSciences Holdings Corporation, Johnson & Johnson, Medtronic plc, Molnlycke Health Care AB and Smith & Nephew plc